However, until the discovery of immune checkpoints, including programed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte protein 4 (CTLA-4), there had not been any breakthroughs in immunotherapy of HCC. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.